hit counter
USA Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Intellia Therapeutics to Present Updated Interim Data from Ongoing Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Hybrid Congress 2023

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Intellia Therapeutics, Inc.

Altimmune to Participate at Two Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Altimmune, Inc. | Analytica Ltd

Generation Bio to Present at the 2023 Jefferies Healthcare Conference

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Generation Bio Co.

Arbutus to Present at Jefferies Healthcare Conference

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Arbutus Biopharma Corporation

TG Therapeutics Announces Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis to be Presented at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  TG Therapeutics, Inc.

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Ventyx Biosciences, Inc.

Cocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Cocrystal Pharma, Inc.

Vaxart Launches New Investor Communication Program, First Event Scheduled for June 15 at 11 a.m. ET

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Vaxart, Inc

Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Lumos Pharma Inc.

Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Aridis Pharmaceuticals Inc.

Sutro Biopharma to Participate in the Jefferies Healthcare Conference

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Sutro Biopharma, Inc.

Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Jefferies Healthcare Conference June 7-8, 2023

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Intercept Pharmaceuticals Inc.

Panbela Announces 1-for-30 Reverse Stock Split Effective June 1, 2023

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Panbela Therapeutics, Inc.

AltruBio to Present at the 2023 BIO International Convention

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  AltruBio Inc.

Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Reneo Pharmaceuticals, Inc.

Erasca to Host Virtual Investor Event on Pipeline Updates with a Focus on ERAS-007 ERK Inhibitor

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Erasca, Inc.

Cabaletta Bio to Present at the Jefferies Healthcare Conference

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Cabaletta Bio, Inc.

Fate Therapeutics to Present at Upcoming June Investor Conferences

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Fate Therapeutics, Inc.

Ardelyx to Present at the Jefferies 2023 Healthcare Conference

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Ardelyx

Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm ™ (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Aquestive Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • June 2023
    • Boston: Product & Company Valuation Course
    • BIO International Convention 2023
    • RESI Boston
See Events »
Add an Event »

Latest company news

Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy
04 Jun 2023 (GlobeNewswire)

Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma
04 Jun 2023 (GlobeNewswire)

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
04 Jun 2023 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com